statistiche ricercatore

Continente	#
EU - Europa	282
AS - Asia	222
NA - Nord America	218
SA - Sud America	55
Continente sconosciuto - Info sul continente non disponibili	19
AF - Africa	13
Totale	809

Nazione	#
RU - Federazione Russa	207
US - Stati Uniti d'America	204
SG - Singapore	114
BR - Brasile	38
CN - Cina	38
HK - Hong Kong	28
IT - Italia	21
VN - Vietnam	13
DE - Germania	12
FR - Francia	11
GB - Regno Unito	8
AR - Argentina	7
IN - India	7
MX - Messico	7
FI - Finlandia	5
ZA - Sudafrica	5
BD - Bangladesh	4
ID - Indonesia	4
CA - Canada	3
PK - Pakistan	3
SE - Svezia	3
CO - Colombia	2
EG - Egitto	2
JP - Giappone	2
LT - Lituania	2
MA - Marocco	2
MY - Malesia	2
PL - Polonia	2
PT - Portogallo	2
PY - Paraguay	2
VE - Venezuela	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BB - Barbados	1
BO - Bolivia	1
CL - Cile	1
DK - Danimarca	1
DZ - Algeria	1
EC - Ecuador	1
ES - Italia	1
ET - Etiopia	1
GD - Grenada	1
GE - Georgia	1
HR - Croazia	1
HU - Ungheria	1
IE - Irlanda	1
JO - Giordania	1
KW - Kuwait	1
LU - Lussemburgo	1
NG - Nigeria	1
NL - Olanda	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
TN - Tunisia	1
TR - Turchia	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	790

Nome	#
68Ga-PSMA-11 PET/MRI versus multiparametric MRI in men referred for prostate biopsy: primary tumour localization and interreader agreement	121
Preliminary Findings of the Role of FAPi in Prostate Cancer Theranostics	120
Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI	89
Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study	77
Correction: PSMA‑positive prostatic volume prediction with deep learning based on T2‑weighted MRI	64
Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer?	62
PSMA-positive prostatic volume prediction with deep learning based on T2-weighted MRI	57
Quantitative imaging parameters to predict the local staging of prostate cancer in intermediate- to high-risk patients	57
Can We Predict Skeletal Lesion on Bone Scan Based on Quantitative PSMA PET/CT Features?	55
Unspecic bone uptakes in PSMA PET for prostate cancer: why do they matter?	52
Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga] Ga‑PSMA‑11 PET scans of primary prostate cancer	50
Is there a role for early SSTR-targeting PRRT in GEP-NET?	5
Totale	809

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	7	0	0	0	0	0	0	0	0	0	7	0	0
2023/2024	9	0	1	0	1	0	1	0	4	0	1	0	1
2024/2025	154	0	0	0	3	12	3	28	9	33	15	23	28
2025/2026	615	57	40	28	44	77	101	67	62	88	35	9	7
2026/2027	24	19	5	0	0	0	0	0	0	0	0	0	0
Totale													809